Cargando…

Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson’s Disease Stages?

INTRODUCTION: Magnetic resonance imaging (MRI) can be used to identify biomarkers in Parkinson’s disease (PD); R2* values reflect iron content related to high levels of oxidative stress, whereas volume and/or shape changes reflect neuronal death. We sought to assess iron overload in the nigrostriata...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hopes, Lucie, Grolez, Guillaume, Moreau, Caroline, Lopes, Renaud, Ryckewaert, Gilles, Carrière, Nicolas, Auger, Florent, Laloux, Charlotte, Petrault, Maud, Devedjian, Jean-Christophe, Bordet, Regis, Defebvre, Luc, Jissendi, Patrice, Delmaire, Christine, Devos, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818028/ https://www.ncbi.nlm.nih.gov/pubmed/27035571 http://dx.doi.org/10.1371/journal.pone.0147947

Ejemplares similares

Ceruloplasmin activity and iron chelation treatment of patients with Parkinson’s disease
por: Grolez, Guillaume, et al.
Publicado: (2015)

MRI of the cervical spinal cord predicts respiratory dysfunction in ALS
por: Grolez, G., et al.
Publicado: (2018)

Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?
por: Moreau, Caroline, et al.
Publicado: (2018)

Dose-dependent metabolite changes after ethanol intoxication in rat prefrontal cortex using in vivo magnetic resonance spectroscopy
por: Carton, Louise, et al.
Publicado: (2019)

The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review
por: Grolez, G., et al.
Publicado: (2016)

Long-Term Risperidone Treatment Induces Visceral Adiposity Associated with Hepatic Steatosis in Mice: A Magnetic Resonance Approach
por: Auger, Florent, et al.
Publicado: (2014)

Lack of direct involvement of a diazepam long-term treatment in the occurrence of irreversible cognitive impairment: a pre-clinical approach
por: Carton, Louise, et al.
Publicado: (2021)

PPAR-Alpha Agonist Used at the Acute Phase of Experimental Ischemic Stroke Reduces Occurrence of Thrombolysis-Induced Hemorrhage in Rats
por: Gautier, Sophie, et al.
Publicado: (2015)

Evidence for the Use of Isoflurane as a Replacement for Chloral Hydrate Anesthesia in Experimental Stroke: An Ethical Issue
por: Maud, Pétrault, et al.
Publicado: (2014)

Erratum to “Evidence for the Use of Isoflurane as a Replacement for Chloral Hydrate Anesthesia in Experimental Stroke: An Ethical Issue”
por: Pétrault, Maud, et al.
Publicado: (2014)

Hallucinations and conscious access to visual inputs in Parkinson’s disease
por: Lefebvre, Stéphanie, et al.
Publicado: (2016)

Texture-based markers from structural imaging correlate with motor handicap in Parkinson’s disease
por: Betrouni, Nacim, et al.
Publicado: (2021)

Time-Induced Progressive Alteration of Kir Current in Cerebral Smooth Muscle Cells of Stroke-Prone Spontaneously Hypertensive Rats
por: Bastide, Michèle, et al.
Publicado: (2013)

Early occurrence of inspiratory muscle weakness in Parkinson’s disease
por: Baille, Guillaume, et al.
Publicado: (2018)

Intracerebroventricular dopamine for Parkinson's disease
por: Devos, David, et al.
Publicado: (2017)

Impact of the neutrophil response to granulocyte colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental stroke
por: Gautier, Sophie, et al.
Publicado: (2014)

The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates
por: Nebie, Ouada, et al.
Publicado: (2019)

Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
por: Moreau, Caroline, et al.
Publicado: (2013)

Conservative Iron Chelation for Neuroferritinopathy
por: Marchand, Felix, et al.
Publicado: (2022)

Influence of Medication on Fatigue Six Months after Stroke
por: Ponchel, Amélie, et al.
Publicado: (2016)

Intracerebral Hemorrhage-Induced Cognitive Impairment in Rats Is Associated With Brain Atrophy, Hypometabolism, and Network Dysconnectivity
por: Puy, Laurent, et al.
Publicado: (2022)

Ventilatory Dysfunction in Parkinson’s Disease
por: Baille, Guillaume, et al.
Publicado: (2016)

Allopregnanolone and neurogenesis in the nigrostriatal tract
por: Wang, Jun Ming
Publicado: (2014)

Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson's disease()
por: Ziegler, Erik, et al.
Publicado: (2014)

Naringin: A Protector of the Nigrostriatal Dopaminergic Projection
por: Jung, Un Ju, et al.
Publicado: (2014)

Are Upper-Body Axial Symptoms a Feature of Early Parkinson’s Disease?
por: Moreau, Caroline, et al.
Publicado: (2016)

Cerebellum: links between development, developmental disorders and motor learning
por: Manto, Mario U., et al.
Publicado: (2012)

Postsynaptic nigrostriatal dopamine receptors and their role in movement regulation
por: Korchounov, Alexei, et al.
Publicado: (2010)

Nigrostriatal dopaminergic depletion increases static orofacial allodynia
por: Dieb, Wisam, et al.
Publicado: (2016)

The amygdalo-nigrostriatal network is critical for an optimal temporal performance
por: Es-seddiqi, Mouna, et al.
Publicado: (2016)

Deterministic Tractography of the Nigrostriatal-Nigropallidal Pathway in Parkinson’s Disease
por: Tan, Wen-Qi, et al.
Publicado: (2015)

Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic Neurotransmission
por: Qin, Qi, et al.
Publicado: (2016)

GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain
por: Nikolaus, Susanne, et al.
Publicado: (2018)

STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy
por: Hinkle, Jared T., et al.
Publicado: (2022)

Nigrostriatal dopamine pathway regulates auditory discrimination behavior
por: Chen, Allen P. F., et al.
Publicado: (2022)

Past and Future of Neurotrophic Growth Factors Therapies in ALS: From Single Neurotrophic Growth Factor to Stem Cells and Human Platelet Lysates
por: Gouel, Flore, et al.
Publicado: (2019)

Synthetic MRI for stroke: a qualitative and quantitative pilot study
por: André, Joachim, et al.
Publicado: (2022)

Ruptured Renal Angiomyolipoma
por: Azzi, Sébastien, et al.
Publicado: (2022)

Serum Cholesterol and Nigrostriatal R2* Values in Parkinson's Disease
por: Du, Guangwei, et al.
Publicado: (2012)

Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration
por: Mor, Danielle E., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e5ftj84h1g4isvmjo0qkr13nl2